361-04-010 ISMRM Abstract

Selective Fluid Suppression in APTw Imaging Using a Sigmoid-Based Spillover Correction with ssMT Preservation

Primary: Contrast Mechanisms - CEST / APT / NOE

Secondary: Neuro - Tumors

361-04-010 · Advanced Neuroimaging with MRI: CEST and APT Techniques · Monday, 11 May, 2:45 PM–3:40 PM · Digital Posters Row B

Keywords: Tumors Correction algorithm Amide proton transfer-weighted Fluid suppression Semi solid magnetic tranfer

Accepted

Stefano Casagranda ¹, Christos Papageorgakis¹, Mauro Zucchelli¹, Capucine Cadin², Francesca Branzoli², Lucia Nichelli^2,3, Moritz Zaiss⁴, Patrick Liebig⁵

¹Innovation Lab, Olea Medical, La Ciotat, France

²Paris Brain Institute - ICM, INSERM U 1127, CNRS UMR 7225, Sorbonne University, Paris, France

³Assistance Publique-Hôpitaux de Paris, Groupe Hospitalier Pitié-Salpêtrière-Charles-Foix, Paris, France

⁴Department of Neuroradiology, Friedrich-Alexander Universität Erlangen-Nürnberg (FAU), Erlangen, Germany

⁵Siemens Healthineers AG, Erlangen, Germany

Presenting Author: Stefano Casagranda

Synopsis

Motivation:

Goals:

Approach:

Results:

Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

References

1. Heo, Hye‐Young, et al. "Unraveling contributions to the Z‐spectrum signal at 3.5 ppm of human brain tumors." Magnetic resonance in medicine 92.6 (2024): 2641-2651, doi: 10.1002/mrm.30241 [doi]

2. Zaiss, Moritz, et al. "Inverse Z‐spectrum analysis for spillover‐, MT‐, and T1‐corrected steady‐state pulsed CEST‐MRI–application to pH‐weighted MRI of acute stroke." NMR in biomedicine 27.3 (2014): 240-252, doi: 10.1002/nbm.3054 [doi]

3. Schüre, Jan‐Rüdiger, et al. "Fluid suppression in amide proton transfer‐weighted (APTw) CEST imaging: New theoretical insights and clinical benefits." Magnetic Resonance in Medicine 91.4 (2024): 1354-1367. doi: 10.1002/mrm.29915 [doi]

4. Deshmane, Anagha, et al. "3D gradient echo snapshot CEST MRI with low power saturation for human studies at 3T." Magnetic resonance in medicine 81.4 (2019): 2412-2423. doi: 10.1002/mrm.27569 [doi]

5. Zhou, Jinyuan, et al. "Review and consensus recommendations on clinical APT‐weighted imaging approaches at 3T: application to brain tumors." Magnetic resonance in medicine 88.2 (2022): 546-574. doi: 10.1002/mrm.29241 [doi]

6. Schuenke, Patrick, et al. "Simultaneous mapping of water shift and B1 (WASABI)—application to field‐inhomogeneity correction of CEST MRI data." Magnetic resonance in medicine 77.2 (2017): 571-580. doi: 10.1002/mrm.26133 [doi]

7. Buckheit, Jonathan, et al. "About wavelab." Handbook of WaveLab Version 850 (1995): 1-37. doi: 10.1007/978-1-4612-2544-7_5 [doi]

8. Casagranda, Stefano et al., ‘Principal Component selections and filtering by spatial information criteria for multi-acquisition CEST MRI denoising’, ISMRM, London, UK, p.2080, 2022, [Online]. Available: https://archive.ismrm.org/2022/2080.html

9. Klein, Stefan, et al. "Elastix: a toolbox for intensity-based medical image registration." IEEE transactions on medical imaging 29.1 (2009): 196-205, doi: 10.1109/tmi.2009.2035616 [doi]

10. Wu, B., et al. "An overview of CEST MRI for non-MR physicists." EJNMMI physics 3.1 (2016): 19. doi: 10.1186/s40658-016-0155-2 [doi]

11. Papageorgakis, Christos, et al., ‘Decorrelation Algorithm for Correcting B1 Artifacts in APTw Imaging at 3 Tesla’, ISMRM, Singapore, p.4469, 2024, [Online]. Available: https://archive.ismrm.org/2024/4469.html

12. Papageorgakis, Christos, et al. "Fast WASABI post-processing: Access to rapid B0 and B1 correction in clinical routine for CEST MRI." Magnetic resonance imaging 102 (2023): 203-211. doi: 10.1016/j.mri.2023.06.001 [doi]

13. L. Mancini et al., ‘CEST MRI provides amide/amine surrogate biomarkers for treatment-naïve glioma sub-typing’, Eur J Nucl Med Mol Imaging, vol. 49, no. 7, pp. 2377–2391, Jun. 2022, doi: 10.1007/s00259-022-05676-1. [doi]

14. S. Casagranda et al. Fluid suppression in CEST imaging affects predominantly IDH-mutant 1p/19q retained gliomas with T2-FLAIR mismatch. In: ISMRM 29th Annual Meeting. 2020.

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/361-04-010